Principal Financial Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-285,699
| Closed | -$52.5M | – | 2655 |
|
|
2021
Q2 | $52.5M | Buy |
285,699
+6,851
| +2% | +$1.18M | 0.03% | 421 |
|
|
2021
Q1 | $42.6M | Sell |
278,848
-14,526
| -5% | -$2.25M | 0.03% | 486 |
|
|
2020
Q4 | $45.8M | Sell |
293,374
-17,235
| -6% | -$2.21M | 0.03% | 406 |
|
|
2020
Q3 | $35.5M | Sell |
310,609
-20,692
| -6% | -$2.23M | 0.03% | 452 |
|
|
2020
Q2 | $37.2M | Buy |
331,301
+17,353
| +6% | +$1.84M | 0.03% | 424 |
|
|
2020
Q1 | $28.2M | Buy |
313,948
+271
| +0.1% | +$26.6K | 0.03% | 439 |
|
|
2019
Q4 | $33.9M | Sell |
313,677
-25,354
| -7% | -$2.71M | 0.03% | 517 |
|
|
2019
Q3 | $33.2M | Sell |
339,031
-1,892
| -0.6% | -$213K | 0.03% | 505 |
|
|
2019
Q2 | $44.7M | Buy |
340,923
+13,718
| +4% | +$1.77M | 0.04% | 418 |
|
|
2019
Q1 | $44.2M | Sell |
327,205
-1,039
| -0.3% | -$129K | 0.04% | 426 |
|
|
2018
Q4 | $32M | Sell |
328,244
-4,048
| -1% | -$478K | 0.03% | 484 |
|
|
2018
Q3 | $46.2M | Buy |
332,292
+6,396
| +2% | +$802K | 0.04% | 443 |
|
|
2018
Q2 | $40.5M | Buy |
325,896
+1,072
| +0.3% | +$125K | 0.04% | 461 |
|
|
2018
Q1 | $36.2M | Sell |
324,824
-4,307
| -1% | -$515K | 0.03% | 502 |
|
|
2017
Q4 | $39.4M | Buy |
329,131
+6,017
| +2% | +$733K | 0.04% | 485 |
|
|
2017
Q3 | $45.3M | Sell |
323,114
-12,411
| -4% | -$1.69M | 0.04% | 435 |
|
|
2017
Q2 | $40.8M | Buy |
335,525
+4,115
| +1% | +$479K | 0.04% | 464 |
|
|
2017
Q1 | $40.2M | Buy |
331,410
+5,137
| +2% | +$662K | 0.05% | 402 |
|
|
2016
Q4 | $39.9M | Sell |
326,273
-1,546
| -0.5% | -$189K | 0.05% | 380 |
|
|
2016
Q3 | $40.2M | Buy |
327,819
+7,006
| +2% | +$902K | 0.05% | 361 |
|
|
2016
Q2 | $37.5M | Sell |
320,813
-1,368
| -0.4% | -$194K | 0.05% | 338 |
|
|
2016
Q1 | $44.9M | Buy |
322,181
+5,471
| +2% | +$803K | 0.07% | 287 |
|
|
2015
Q4 | $60.4M | Buy |
316,710
+7,145
| +2% | +$1.25M | 0.09% | 240 |
|
|
2015
Q3 | $48.4M | Buy |
309,565
+13,574
| +5% | +$2.48M | 0.08% | 274 |
|
|
2015
Q2 | $53.5M | Buy |
295,991
+29,788
| +11% | +$5.14M | 0.08% | 265 |
|
|
2015
Q1 | $46.1M | Buy |
266,203
+8,490
| +3% | +$1.54M | 0.07% | 291 |
|
|
2014
Q4 | $47.7M | Buy |
257,713
+9,622
| +4% | +$1.78M | 0.07% | 280 |
|
|
2014
Q3 | $41.1M | Buy |
248,091
+4,072
| +2% | +$669K | 0.07% | 294 |
|
|
2014
Q2 | $38.1M | Sell |
244,019
-19,548
| -7% | -$3.09M | 0.06% | 321 |
|
|
2014
Q1 | $40.1M | Buy |
263,567
+8,373
| +3% | +$1.33M | 0.07% | 312 |
|
|
2013
Q4 | $34M | Buy |
255,194
+1,487
| +0.6% | +$178K | 0.06% | 340 |
|
|
2013
Q3 | $29.5M | Buy |
253,707
+854
| +0.3% | +$93.7K | 0.06% | 342 |
|
|
2013
Q2 | $23.3M | Buy |
+252,853
| New | +$24.4M | 0.05% | 379 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM